Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy

Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: The CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (CanACTFAST) study

(2011) Ehud Ur et al.   CANADIAN JOURNAL OF CARDIOLOGY

Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels

(2011) Yuki Horiuchi et al.   Journal of Atherosclerosis and Thrombosis

Effects of fluvastatin therapy on serum interleukin-18 and interleukin-10 levels in patients with acute coronary syndrome

(2010) Y. Liu et al.   ACTA CARDIOLOGICA

The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)

(2010) S G Lakoski et al.   JOURNAL OF HUMAN HYPERTENSION

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: Results of the CAP (Comparative Atorvastatin Pleiotropic effects) study

(2009) Jacques Bonnet et al.   CLINICAL THERAPEUTICS

The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease

(2009) Simon W Rabkin   Nature Reviews Cardiology

Reduction in Blood Pressure With StatinsResults From the UCSD Statin Study, a Randomized Trial

(2008) Beatrice A. Golomb   ARCHIVES OF INTERNAL MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study

(2007) Scott Kinlay et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Simvastatin exerts its anti-inflammatory effect in hypercholesterolaemic patients by decreasing the serum levels of monocyte chemoattractant protein-1

(2007) Loukianos S. Rallidis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY